BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37071628)

  • 61. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
    Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
    Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Costs of schizophrenia and other psychoses in urban Australia: findings from the Low Prevalence (Psychotic) Disorders Study.
    Carr VJ; Neil AL; Halpin SA; Holmes S; Lewin TJ
    Aust N Z J Psychiatry; 2003 Feb; 37(1):31-40. PubMed ID: 12534654
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Costs of care associated with non-small-cell lung cancer in a commercially insured cohort.
    Hillner BE; McDonald MK; Desch CE; Smith TJ; Penberthy LT; Maddox P; Retchin SM
    J Clin Oncol; 1998 Apr; 16(4):1420-4. PubMed ID: 9552046
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bipolar disorders in Australia. A population-based study of excess costs.
    Fisher LJ; Goldney RD; Dal Grande E; Taylor AW; Hawthorne G
    Soc Psychiatry Psychiatr Epidemiol; 2007 Feb; 42(2):105-9. PubMed ID: 17080320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada.
    Isaranuwatchai W; de Oliveira C; Mittmann N; Evans WKB; Peter A; Truscott R; Chan KK
    BMJ Open; 2019 Jun; 9(6):e026022. PubMed ID: 31230002
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors influencing the cost of hospital care for people with diabetes in Australia.
    Clarke P; Kelman C; Colagiuri S
    J Diabetes Complications; 2006; 20(6):349-55. PubMed ID: 17070437
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disparities in breast screening, stage at diagnosis, cancer treatment and the subsequent risk of cancer death: a retrospective, matched cohort of aboriginal and non-aboriginal women with breast cancer.
    Banham D; Roder D; Keefe D; Farshid G; Eckert M; Howard N; Canuto K; Brown A;
    BMC Health Serv Res; 2019 Jun; 19(1):387. PubMed ID: 31200700
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hospitalization costs of adult community-acquired pneumonia in England.
    Campling J; Wright HF; Hall GC; Mugwagwa T; Vyse A; Mendes D; Slack MPE; Ellsbury GF
    J Med Econ; 2022; 25(1):912-918. PubMed ID: 35726515
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia.
    Callander E; Bates N; Lindsay D; Larkins S; Topp SM; Cunningham J; Sabesan S; Garvey G
    Int J Equity Health; 2019 Feb; 18(1):32. PubMed ID: 30755217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The excess cost of depression in South Australia: a population-based study.
    Hawthorne G; Cheok F; Goldney R; Fisher L
    Aust N Z J Psychiatry; 2003 Jun; 37(3):362-73. PubMed ID: 12780477
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.
    Gordon LG; Tuffaha HW; James R; Keller AT; Lowe A; Scuffham PA; Gardiner RA
    Urol Oncol; 2018 Mar; 36(3):91.e7-91.e15. PubMed ID: 29169847
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Total and out-of-pocket costs of different primary management strategies in ovarian cancer.
    Suidan RS; He W; Sun CC; Zhao H; Rauh-Hain JA; Fleming ND; Lu KH; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2019 Aug; 221(2):136.e1-136.e9. PubMed ID: 30965052
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hospital utilization, costs and mortality rates during the first 5 years of life: a population study of ART and non-ART singletons.
    Chambers GM; Lee E; Hoang VP; Hansen M; Bower C; Sullivan EA
    Hum Reprod; 2014 Mar; 29(3):601-10. PubMed ID: 24310618
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Costs of cancer care in children and adolescents in Ontario, Canada.
    de Oliveira C; Bremner KE; Liu N; Greenberg ML; Nathan PC; McBride ML; Krahn MD
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28500732
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The cost of care for children hospitalised with Invasive Group A Streptococcal Disease in Australia.
    Brusco NK; Oliver J; McMinn A; Steer A; Crawford N
    BMC Health Serv Res; 2021 Dec; 21(1):1340. PubMed ID: 34906126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 80. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
    Alsop K; Fereday S; Meldrum C; deFazio A; Emmanuel C; George J; Dobrovic A; Birrer MJ; Webb PM; Stewart C; Friedlander M; Fox S; Bowtell D; Mitchell G
    J Clin Oncol; 2012 Jul; 30(21):2654-63. PubMed ID: 22711857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.